Verified intelligence · Expert-reviewed from public records, platform data, primary sources, and private research beyond AI search.
INFRAHealthcare deliveryGLOBAL
AI infrastructure for hospitals and health systems
Hospital AI infrastructure should control patient context: identity-bound PHI access, FHIR and EHR normalization, retrieval provenance, model-channel policy, audit evidence, downtime recovery and write-back.
The colophon
- Landscape reviewed
- 2026-06-02
- Latest revision
- 2026-06-02
- Kinetics
- Kinetics: activeImpact 0.90 · momentum 0.83 · vector 0.758 balls · 41 px/s
Hospital AI infrastructure centres on the patient-context layer that controls PHI exposure, EHR write-back and reusable integration. EHR integration reuse, TEFCA purpose controls, AI assurance artefacts, PHI audit demands and clinical write-back risks are moving context decisions ahead of refresh cycles.
- Known unknowns
- Reference hospital patient-context workloads linking identity-bound PHI access, FHIR/EHR retrieval quality, model-channel handling, audit export, failover, write-back, support burden, retest triggers and cost per accepted workflow.
Contents
Executive summary
Every hospital AI pilot becomes a separate EHR/FHIR integration, PHI review, rollback path and support queue unless one patient-context service owns source, reviewer state and write-back evidence across workflows. Interoperability makes more health records reachable. It does not decide which patient facts a model may see, how long they may persist or where the answer may return.
HIPAA security work keeps ePHI controls and system accountability in scope 3. Record exchange makes more patient facts reachable, but the buyer still has to bind purpose, PHI scope, reviewer state, write-back authority and recovery evidence before a model sees them.
The trap is letting every AI vendor create its own context store. That produces duplicate integrations, inconsistent PHI boundaries, unclear rollback and audit evidence that cannot survive a security or clinical review.
For global buyers, treat CMS, HIPAA, HTI-1, TEFCA and U.S. CDS/device evidence as concrete control examples, then substitute local privacy, residency, interoperability, device/CDS and exchange obligations before procurement.
Fund reusable access and write-back controls as infrastructure: approved EHR/FHIR/DICOM/document inputs, governed model channels 11,13, reviewer state and reversible queue, note or task outputs 20. Treat SMART launch and backend authorization as implementation-guide diligence, then verify the selected version and local conformance before contract acceptance 18,19. Recovery needs a separate downtime and rollback test 23.
Start with one high-volume workflow, but build the context interface as reusable infrastructure: PHI scope, source provenance, model-channel evidence and signer state.
Measure reuse and accepted output together: fewer bespoke integrations, visible reviewer action, safe rollback and lower support burden.
The buying decision
| Question | Answer | Action |
|---|---|---|
| What should the board fund? | A reusable hospital-owned evidence path that reduces duplicate EHR/FHIR integrations, PHI review burden, support load, rollback cost and write-back risk across at least two workflows. | Approve funding only when two workflows share the same access rules, reviewer-state capture, audit export, write-back authority and recovery telemetry. |
| What changed? | Record reachability is no longer the scarce layer; the scarce layer is hospital-owned context proof: purpose, PHI scope, source, retention, reviewer state and write-back boundary 1,3. | Expand record access only through source, purpose, PHI class, model-channel and retention controls. |
| What should remain blocked? | Vendor-specific context stores, unreviewed EHR write-back and outputs that cannot be traced to source records. | Require audit export, rollback, downtime and reviewer-state evidence before scale 23. |
| Who owns the trigger? | CIO, CISO and clinical informatics should approve the patient-context layer before scaling PHI-bearing model workflows or EHR write-back. | Use AI rollout, EHR integration strategy, vendor renewal or write-back governance as the budget trigger. |
What changed
Public evidence is now structured enough to define private approval tests. More record access, more model channels and more clinical write-back create context sprawl unless one owner controls source, purpose, PHI scope and rollback. Purpose, PHI scope, source provenance, reviewer state and rollback have to be bound before reachable records become model context. Standards are useful only when a hospital-owned context layer applies that control record across FHIR, TEFCA and model-channel work 1,5. TEFCA-connected access adds exchange-purpose, identity-proofing and incident-escalation constraints 16,17.
Make the context layer a reusable product with three interfaces: approved inputs from EHR, FHIR, DICOM and documents; governed model channels with model-card and red-team evidence; and reversible outputs to queues, notes, tasks and other clinical systems.
For high-risk workflows, the approval record has to connect source evidence, accepted output, reviewer action, exception path, outcome signal and retained audit record before volume or staffing claims matter.
Triggers that change approval timing
| Trigger | Why it matters | Decision use |
|---|---|---|
| CMS FHIR API requirements 1 | Payer, provider and prior-authorization records become an integration dependency. | Define context bundles for FHIR scopes, payer records and prior-auth evidence before adding model channels. |
| TEFCA and broader record exchange 5 | More cross-organization data can enter the hospital record and AI context. | Tag incoming records with source, exchange purpose, identity proofing, reuse limit and provenance before retrieval 16,20. |
| HIPAA cybersecurity pressure 3 | PHI-bearing prompts, retrieval results and model logs become ePHI movement to inventory and protect. | Treat model channels, context stores and audit logs as part of the ePHI system map. |
| HTI-1 decision-support transparency 2 | Supplied decision support needs source attributes and risk-management evidence. | Store source, model, intervention, model-card and reviewer metadata when output is created 15. |
| NIST and FDA model-channel controls | Generative and regulated AI functions need different risk, red-team, CDS and change-control evidence. | Classify generative channels by PHI class and red-team evidence 13. Classify regulated CDS or device-like channels by intended use, reviewability, model version and retest trigger 21,22. |
Decision map
Workflow approval changes by authority, source boundary and proof burden. Fund the patient-context layer first: the infrastructure that turns reachable PHI into permitted model context and safe clinical-system updates. The decision map should start with a patient-context layer with PHI scope, identity, source provenance, model-channel policy, reviewer state, write-back authority and recovery evidence: what source record is read, what output is drafted, who approves it, where it is stored and what event forces reapproval.
A system can pass a low-risk support test and still fail production work: source evidence, accepted output, integration state, exception handling, reviewer burden and downstream rework have to hold together.
The useful vendor question is whether the system can make the named task inspectable, reversible and measurable inside the operating record.
Workflow selection
| Workflow | Accepted work | Approval gate | Approval rule |
|---|---|---|---|
| Patient-context layer | Permitted context bundle for one workflow: patient, encounter, source records, purpose, user role, retention state and exception flag. | Minimum-necessary PHI scope, identity binding, consent or residency rule where relevant, retrieval provenance, applied model-card link and audit export 15,20. | Own this layer or contract for it explicitly; do not let each AI vendor define patient context separately. |
| Health-data foundation | Normalized FHIR, HL7v2 and DICOM records 8,9, plus document records that preserve source system, update time and data-use limits. | Use SMART launch and backend authorization guides as diligence inputs, then verify the selected version, local scope and production EHR conformance before approval 18,19. Downtime extract and contingency handling need a separate test 23. | Use cloud health-data services for normalization and operations; keep context rights and clinical acceptance outside the data store. |
| Model-channel gateway | Prompt and retrieval package sent only to a permitted model channel with retention, logging and training limits. | BAA or local equivalent, encryption, log access, model-training exclusion, residency, red-team evidence and incident evidence 11,13. | Approve model channels by PHI class and workflow, not by model brand. |
| Controlled EHR write-back | Draft note, task, queue update or order-support field held for named reviewer action before record change. | Role-based permission, source evidence, signer state and provenance should stay linked to the record path 20. CDS boundary, model version and change-control status require separate FDA checks 21,22. | Treat write-back as clinical record infrastructure, not an app-integration checkbox. |
| Recovery and audit export | Manual fallback, audit package and reversal record when model, integration or EHR path fails. | Downtime runbook, log export, incident owner, rollback test and retest trigger 23. | Do not scale a context-dependent workflow until the manual route is tested. |
Reuse proof by workflow
| workflow | accepted output | reviewer | write authority | stop condition |
|---|---|---|---|---|
| Prior authorization and RCM | Context bundle with payer requirement, chart evidence, submission status and denial reason. | RCM or service-line owner accepts, corrects or returns the packet. | Draft packet and status update only until reviewer action and audit export are retained. | Block when local FHIR scope and source provenance have not been verified against the selected implementation guide and production EHR path 18,20, or when fallback queue and rollback evidence are missing 23. |
| Clinical documentation and inbox | Context bundle with encounter, message, source notes, reviewer state and proposed record change. | Clinician signs, edits or rejects the draft before EHR write-back. | Draft first; commit only with role permission, signer state and provenance. | Block when PHI scope, model-channel rule or audit export is incomplete 3,20. |
| Care coordination | Task, referral or follow-up context with source records, owner, patient-contact rule and exception state. | Care-team owner accepts, edits or closes the task. | Queue or task update only after identity, source, owner and recovery evidence are retained. | Block when downtime, incident owner or manual fallback has not been tested 23. |
Write authority changes the proof burden
Use the matrix to decide what proof is required before each workflow becomes accepted work.
Glossary
Terms used in this report
| Term | Plain meaning |
|---|---|
| Route | The approved path from work to accepted output: source set, data boundary, model or vendor channel, tools, reviewer, evidence record and reapproval trigger. |
| API | Application programming interface: a governed software connection used by an app or workflow to call a model or service. |
| Token | A chunk of text used for billing, context windows and rate limits. It is usually smaller than a word, not a page count. |
| OCR | Optical character recognition: converting scanned or image text into machine-readable text. |
Definitions are reader aids, not separate evidence claims.
MCP PREVIEW INVENTORY
What the locked report contains
Hospital AI infrastructure should control patient context: identity-bound PHI access, FHIR and EHR normalization, retrieval provenance, model-channel policy, audit evidence, downtime recovery and write-back.
Schema endpoints
- Sample object: /api/v1/reports/RPT_HEALTHCARE_DELIVERY_AI_INFRA_HOSPITALS/sample
- Inventory object: /api/v1/reports/RPT_HEALTHCARE_DELIVERY_AI_INFRA_HOSPITALS/inventory
- Schema contract: /api/v1/reports/RPT_HEALTHCARE_DELIVERY_AI_INFRA_HOSPITALS/schema
Coverage fields
- Category: INFRA
- Sector: Healthcare delivery
- Region: GLOBAL
- Topics: hospital AI infrastructure, FHIR, EHR integration, PHI, HIPAA, TEFCA, model routing, audit logs, healthcare data platforms, clinical workflow integration
Schema contract
- Contract: colophon.report_document v2026-05-28
- Payload schemas: document, summary, sample, inventory, full_report
- Required top-level fields: title, subtitle, abstract, category, sector, region, topics, sources, evidence, claims, colophon, body
- Integrity rules: evidence.sourceId must reference sources[].id claim.evidenceIds[] must reference evidence[].id evidence.claimIds[] must reference claims[].id section and block evidence references must resolve colophon.kinetics.speed must match the momentum band for the business impact x momentum model
Data-point inventory
- vendor_or_actor_ledger: entity names; product categories; source references; confidence notes
- buyer_decision_fields: pricing signals; deployment constraints; risk flags; monitoring fields
- evidence_index: source class; access date; claim linkage; verification status
Section inventory
- 1. Executive summaryPreview
decision-ready conclusions; major findings; confidence caveats
- 2. What changedPreview
structured findings; supporting evidence; buyer-use fields
- 3. Decision mapPreview
selection criteria; tradeoff map; recommended buyer actions
- 4. Signature proofLocked
structured findings; supporting evidence; buyer-use fields
- 5. Deployment controlsLocked
structured findings; supporting evidence; buyer-use fields
- 6. Workflow selectionLocked
structured findings; supporting evidence; buyer-use fields
- 7. Evidence fitLocked
claim support; known gaps; verification notes; 33 evidence objects
- 8. Private eval designLocked
structured findings; supporting evidence; buyer-use fields
- 9. Risks and controlsLocked
structured findings; supporting evidence; buyer-use fields
- 10. Operating modelLocked
structured findings; supporting evidence; buyer-use fields
- 11. EconomicsLocked
structured findings; supporting evidence; buyer-use fields
- 12. Public claim testsLocked
structured findings; supporting evidence; buyer-use fields
- 13. Diligence directoryLocked
structured findings; supporting evidence; buyer-use fields
- 14. Recommended next stepsLocked
structured findings; supporting evidence; buyer-use fields
- 15. Known unknownsLocked
structured findings; supporting evidence; buyer-use fields
- 16. Source ledgerLocked
normalized entity rows; source ledger; evidence-to-claim mapping
- 17. GlossaryPreview
structured findings; supporting evidence; buyer-use fields
Relevance signals
- Confidence score: 0.88
- Source classes: regulation, health_it_rule, privacy_security_rule, data_standard, interoperability_framework, ehr_developer_docs, cloud_docs, model_provider_security, integration_platform_docs, standard, health_ai_assurance, interoperability_sop, implementation_guide, device_guidance, privacy_security_guidance, vendor_directory
- Known unknowns: Reference hospital patient-context workloads linking identity-bound PHI access, FHIR/EHR retrieval quality, model-channel handling, audit export, failover, write-back, support burden, retest triggers and cost per accepted workflow.
- Watch signals:
Locked continuation
Purchase or subscribe to unlock the full findings, evidence ledger, and buyer-ready recommendations.